Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | FRHC | FHN |
|---|---|---|
| Price | $173.49 | $23.36 |
| Change today | ▲ 0.28% | ▼ 0.26% |
| Market cap | $11.07B | $11.07B |
| Return, 3 months | +13.4% | -8.7% |
| Return, year to date | +42.6% | -0.1% |
| Return, 1 year | +3.2% | +4.2% |
| P/E (TTM) | 71.7 | 11.2 |
| P/B | 7.2 | 1.3 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 2.74% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 57 | 41 |
| 30-day volatility | 45.7% | 17.3% |
| Max drawdown, 1 year | -35.5% | -16.5% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
